Annual SGA
$57.93 M
+$17.98 M+45.00%
December 31, 2023
Summary
- As of February 7, 2025, PLRX annual SGA is $57.93 million, with the most recent change of +$17.98 million (+45.00%) on December 31, 2023.
- During the last 3 years, PLRX annual SGA has risen by +$40.66 million (+235.45%).
- PLRX annual SGA is now at all-time high.
Performance
PLRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$14.26 M
-$762.00 K-5.07%
September 30, 2024
Summary
- As of February 7, 2025, PLRX quarterly SGA is $14.26 million, with the most recent change of -$762.00 thousand (-5.07%) on September 30, 2024.
- Over the past year, PLRX quarterly SGA has dropped by -$762.00 thousand (-5.07%).
- PLRX quarterly SGA is now -7.08% below its all-time high of $15.35 million, reached on September 30, 2023.
Performance
PLRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.31 B
-$201.68 M-9.57%
September 30, 2024
Summary
- As of February 7, 2025, PLRX TTM SGA is -$2.31 billion, with the most recent change of -$201.68 million (-9.57%) on September 30, 2024.
- Over the past year, PLRX TTM SGA has dropped by -$2.37 billion (-3983.31%).
- PLRX TTM SGA is now -4280.26% below its all-time high of $55.24 million.
Performance
PLRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PLRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.0% | -5.1% | -3983.3% |
| 3 y3 years | +235.4% | -5.1% | -3983.3% |
| 5 y5 years | +791.2% | +359.6% | -10000.0% |
PLRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.2% | -7.1% | +81.8% | -225.3% | at low |
| 5 y | 5-year | at high | +430.0% | -7.1% | +369.1% | -4672.8% | at low |
| alltime | all time | at high | +791.2% | -7.1% | +452.1% | -4280.3% | at low |
Pliant Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $14.26 M(-5.1%) | $58.38 M(-1.8%) |
| Jun 2024 | - | $15.02 M(-1.5%) | $59.47 M(+0.8%) |
| Mar 2024 | - | $15.25 M(+10.0%) | $59.02 M(+1.9%) |
| Dec 2023 | $57.93 M(+45.0%) | $13.85 M(-9.7%) | $57.93 M(-0.7%) |
| Sep 2023 | - | $15.35 M(+5.3%) | $58.33 M(+12.6%) |
| Jun 2023 | - | $14.57 M(+3.0%) | $51.80 M(+13.8%) |
| Mar 2023 | - | $14.15 M(-0.7%) | $45.52 M(+14.0%) |
| Dec 2022 | $39.95 M(+45.0%) | $14.25 M(+61.5%) | $39.95 M(+19.1%) |
| Sep 2022 | - | $8.82 M(+6.4%) | $33.54 M(+3.6%) |
| Jun 2022 | - | $8.30 M(-3.3%) | $32.39 M(+9.5%) |
| Mar 2022 | - | $8.58 M(+9.3%) | $29.57 M(+7.3%) |
| Dec 2021 | $27.56 M | $7.85 M(+2.3%) | $27.56 M(+8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $7.67 M(+40.1%) | $25.34 M(+13.8%) |
| Jun 2021 | - | $5.47 M(-16.6%) | $22.26 M(+12.3%) |
| Mar 2021 | - | $6.57 M(+16.7%) | $19.82 M(+14.8%) |
| Dec 2020 | $17.27 M(+58.0%) | $5.63 M(+22.6%) | $17.27 M(+17.1%) |
| Sep 2020 | - | $4.59 M(+51.0%) | $14.74 M(+15.8%) |
| Jun 2020 | - | $3.04 M(-24.2%) | $12.74 M(+3.2%) |
| Mar 2020 | - | $4.01 M(+29.3%) | $12.34 M(+12.9%) |
| Dec 2019 | $10.93 M(+68.2%) | $3.10 M(+20.1%) | $10.93 M(+39.6%) |
| Sep 2019 | - | $2.58 M(-2.3%) | $7.83 M(+49.3%) |
| Jun 2019 | - | $2.64 M(+1.6%) | $5.24 M(+101.6%) |
| Mar 2019 | - | $2.60 M | $2.60 M |
| Dec 2018 | $6.50 M | - | - |
FAQ
- What is Pliant Therapeutics annual SGA?
- What is the all time high annual SGA for Pliant Therapeutics?
- What is Pliant Therapeutics annual SGA year-on-year change?
- What is Pliant Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly SGA year-on-year change?
- What is Pliant Therapeutics TTM SGA?
- What is the all time high TTM SGA for Pliant Therapeutics?
- What is Pliant Therapeutics TTM SGA year-on-year change?
What is Pliant Therapeutics annual SGA?
The current annual SGA of PLRX is $57.93 M
What is the all time high annual SGA for Pliant Therapeutics?
Pliant Therapeutics all-time high annual SGA is $57.93 M
What is Pliant Therapeutics annual SGA year-on-year change?
Over the past year, PLRX annual SGA has changed by +$17.98 M (+45.00%)
What is Pliant Therapeutics quarterly SGA?
The current quarterly SGA of PLRX is $14.26 M
What is the all time high quarterly SGA for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly SGA is $15.35 M
What is Pliant Therapeutics quarterly SGA year-on-year change?
Over the past year, PLRX quarterly SGA has changed by -$762.00 K (-5.07%)
What is Pliant Therapeutics TTM SGA?
The current TTM SGA of PLRX is -$2.31 B
What is the all time high TTM SGA for Pliant Therapeutics?
Pliant Therapeutics all-time high TTM SGA is $55.24 M
What is Pliant Therapeutics TTM SGA year-on-year change?
Over the past year, PLRX TTM SGA has changed by -$2.37 B (-3983.31%)